Healthcare ❯Pharmaceuticals ❯Diabetes Treatment ❯Sales Performance
The Danish pharmaceutical giant's experimental drug, amycretin, demonstrates significant weight loss in early trials, potentially outperforming its predecessors, Wegovy and Ozempic.
